Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases
Authors
Keywords
-
Journal
INFLAMMATORY BOWEL DISEASES
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-10-22
DOI
10.1093/ibd/izaa278
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis
- (2020) Joseph D. Feuerstein et al. GASTROENTEROLOGY
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China
- (2020) L. Zhang et al. ANNALS OF ONCOLOGY
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Managing Inflammatory Bowel Disease During COVID-19: Summary of Recommendations from Gastrointestinal Societies
- (2020) Jurij Hanzel et al. Clinical Gastroenterology and Hepatology
- Incidence and Patterns of COVID-19 Among Inflammatory Bowel Disease Patients From the Nancy and Milan Cohorts
- (2020) Mariangela Allocca et al. Clinical Gastroenterology and Hepatology
- SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California
- (2020) John Gubatan et al. GASTROENTEROLOGY
- Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry
- (2020) Erica J. Brenner et al. GASTROENTEROLOGY
- AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary
- (2020) David T. Rubin et al. GASTROENTEROLOGY
- Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients with Inflammatory Bowel Disease
- (2020) Dana J. Lukin et al. GASTROENTEROLOGY
- Management of Patients with Crohn’s Disease and Ulcerative Colitis During the COVID-19 Pandemic: Results of an International Meeting
- (2020) David T. Rubin et al. GASTROENTEROLOGY
- Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study
- (2020) Cristina Bezzio et al. GUT
- British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
- (2020) Nicholas A Kennedy et al. GUT
- Expression of SARS-CoV-2 Entry Molecules ACE2 and TMPRSS2 in the Gut of Patients With IBD
- (2020) Juan F Burgueño et al. INFLAMMATORY BOWEL DISEASES
- Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
- (2020) Chi Zhang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China
- (2020) Ruchong Chen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
- (2020) Marc Feldmann et al. LANCET
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Obesity and impaired metabolic health in patients with COVID-19
- (2020) Norbert Stefan et al. Nature Reviews Endocrinology
- Clinical Characteristics of Covid-19 in New York City
- (2020) Parag Goyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
- (2020) Xin Zou et al. Frontiers of Medicine
- Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China
- (2020) Lan Zhu et al. EUROPEAN UROLOGY
- Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome
- (2019) Chelsea Kotch et al. Expert Review of Clinical Immunology
- The Association of Medications and Vaccination with Risk of Pneumonia in Inflammatory Bowel Disease
- (2019) Martin H Gregory et al. INFLAMMATORY BOWEL DISEASES
- The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2019) Sudabeh Alatab et al. Lancet Gastroenterology & Hepatology
- ACG Clinical Guideline: Management of Crohn’s Disease in Adults
- (2018) Gary R Lichtenstein et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Increased Risk of Influenza and Influenza-Related Complications Among 140,480 Patients With Inflammatory Bowel Disease
- (2018) Andrew Tinsley et al. INFLAMMATORY BOWEL DISEASES
- Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)
- (2018) Charlotte Gagnière et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adjuvant use of antibiotics with corticosteroids in inflammatory bowel disease exacerbations requiring hospitalisation: a retrospective cohort study and meta-analysis
- (2015) V. Gupta et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Increased Risk of Pneumonia Among Patients With Inflammatory Bowel Disease
- (2013) Millie D Long et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Increased risk of pneumonia among patients with inflammatory bowel disease: A comparison between patients treated with biologic therapies and with conventional drugs
- (2013) Claudia Romano et al. Journal of Crohns & Colitis
- Older Age Is Associated with Higher Rate of Discontinuation of Anti-TNF Therapy in Patients with Inflammatory Bowel Disease
- (2012) Amit Desai et al. INFLAMMATORY BOWEL DISEASES
- Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults
- (2008) Michael D. Kappelman et al. GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started